TELA Bio
TELA
46 hedge funds and large institutions have $45.5M invested in TELA Bio in 2025 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 11 increasing their positions, 10 reducing their positions, and 12 closing their positions.
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
52% more capital invested
Capital invested by funds: $30M → $45.5M (+$15.5M)
10% more repeat investments, than reductions
Existing positions increased: 11 | Existing positions reduced: 10
2.83% less ownership
Funds ownership: 62.17% → 59.35% (-2.8%)
8% less funds holding
Funds holding: 50 → 46 (-4)
33% less first-time investments, than exits
New positions opened: 8 | Existing positions closed: 12
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NCM
Nantahala Capital Management
New Canaan,
Connecticut
|
+$1.61M |
| 2 |
DWP
Destiny Wealth Partners
Tavares,
Florida
|
+$68.7K |
| 3 |
BlackRock
New York
|
+$42.7K |
| 4 |
Northern Trust
Chicago,
Illinois
|
+$38.3K |
| 5 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
+$37.4K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ACM
AIGH Capital Management
Baltimore,
Maryland
|
-$1.73M |
| 2 |
MBAM
Mink Brook Asset Management
West Palm Beach,
Florida
|
-$436K |
| 3 |
PCM
Pentwater Capital Management
Naples,
Florida
|
-$241K |
| 4 |
Renaissance Technologies
New York
|
-$232K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$111K |
TELA Hedge Fund Activity: Q2 2025 in Review
46 of the 7,596 institutional investors tracked by Wall St. Rank reported a position in TELA Bio (TELA) for Q2 2025, worth a combined $45.5M — up 52% from $30M a quarter earlier.
Sellers outnumbered buyers: 12 funds closed out of TELA and 8 opened new positions — a net loss of 4 holders — while 10 trimmed existing stakes and 11 added.
The largest buyer was Nantahala Capital Management, adding an estimated $1.61M. The largest seller was AIGH Capital Management, exiting entirely with an estimated $1.73M sold.
- 46 institutional investors held TELA Bio (TELA) as of Q2 2025, down from 50 in Q1 2025.
- Funds reported $45.5M of TELA Bio stock for Q2 2025, up 52% quarter-over-quarter.
- 8 funds opened new TELA Bio positions in Q2 2025 and 12 closed out, a net change of -4 holders.
- The largest TELA Bio buyer in Q2 2025 was Nantahala Capital Management, an estimated $1.61M added.
- The largest TELA Bio seller in Q2 2025 was AIGH Capital Management, an estimated $1.73M sold.
Based on aggregated 13F filings for Q2 2025.